AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
84 hedge funds and large institutions have $41.2M invested in Accelerate Diagnostics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
85% less call options, than puts
Call options by funds: $190K | Put options by funds: $1.23M
Holders
84
Holding in Top 10
3
Calls
$190K
Puts
$1.23M
Top Buyers
| 1 | +$5.05M | |
| 2 | +$2.64M | |
| 3 | +$1.63M | |
| 4 |
Millennium Management
New York
|
+$1.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$791K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$360K | |
| 3 | -$131K | |
| 4 |
CIA
Cladis Investment Advisory
Billings,
Montana
|
-$126K |
| 5 |
HF
HRT Financial
New York
|
-$114K |